Capsid-specific T-cell Responses to Natural Infections With Adeno-associated Viruses in Humans Differ From Those of Nonhuman Primates
Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8+ T cells that become reactivated upon gen...
Saved in:
Published in | Molecular therapy Vol. 19; no. 11; pp. 2021 - 2030 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.11.2011
Elsevier Limited Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8+ T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8+ and CD4+ T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species. |
---|---|
AbstractList | Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8 + T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8 + and CD4+ T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species. Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8 + T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8 + and CD4 + T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species. Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8(+) T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8(+) and CD4(+) T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species.Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8(+) T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8(+) and CD4(+) T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species. Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We formulated the hypothesis that rejection of AAV-transduced hepatocytes is caused by AAV capsid-specific CD8 super(+) T cells that become reactivated upon gene transfer. Although this hypothesis was compatible with clinical data, which showed a rise in circulating AAV capsid-specific T cells following injection of AAV vectors, it did not explain that AAV vectors achieved long-term transgene expression in rhesus macaques, which are naturally infected with AAV serotypes closely related to those of humans. To address this apparent contradiction, we tested human and rhesus macaque samples for AAV capsid-specific T cells by intracellular cytokine staining combined with staining for T-cell subset and differentiation markers. This highly sensitive method, which could provide a tool to monitor adverse T-cell responses in gene transfer trials, showed that AAV capsid-specific CD8 super(+) and CD4 super(+) T cells can be detected in blood of naturally infected humans and rhesus macaques. They are present at higher frequencies in rhesus macaques. Furthermore, T cells from humans and rhesus macaques exhibit striking differences in their differentiation status and in their functions, which may explain the disparate duration of AAV-mediated gene transfer in these two species. |
Author | Lasaro, Marcio O Li, Hua Jia, Bei Ertl, Hildegund CJ High, Katherine A Haut, Larissa H Lin, Shih Wen |
Author_xml | – sequence: 1 givenname: Hua surname: Li fullname: Li, Hua organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA – sequence: 2 givenname: Marcio O surname: Lasaro fullname: Lasaro, Marcio O organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA – sequence: 3 givenname: Bei surname: Jia fullname: Jia, Bei organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA – sequence: 4 givenname: Shih Wen surname: Lin fullname: Lin, Shih Wen organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA – sequence: 5 givenname: Larissa H surname: Haut fullname: Haut, Larissa H organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA – sequence: 6 givenname: Katherine A surname: High fullname: High, Katherine A organization: Department of Pediatrics, the Children's Hospital of Philadelphia and Howard Hughes Medical Institute, Philadelphia, Pennsylvania, USA – sequence: 7 givenname: Hildegund CJ surname: Ertl fullname: Ertl, Hildegund CJ email: ertl@wistar.upenn.edu organization: Immunology Program, Wistar Institute, Philadelphia, Pennsylvania, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21587208$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kl1rFDEUhgep2A-98QdIwAtFmDUfk5nMjVBWawuliqx6GbLJiZuyk4xJpuAP8H-bYdvSluJVDjnP-3K-Dqs9HzxU1UuCFwQz8X7IC4oJWQjypDognPIaY9rs3cak3a8OU7osEeF9-6zap4SLjmJxUP1dqjE5U6cRtLNOo1WtYbtF3yCNwSdIKAd0ofIU1RadeQs6u_KPfrq8QccGfKhVSkE7lcGgHy5Os8Z5dDoNqnAfnbUQ0UkMA1ptQgIULLoIfjOn0dfohiJMz6unVm0TvLh-j6rvJ59Wy9P6_Mvns-Xxea0bwXLNDRbtGq9x1xGKraGNAmVZY5iyvG1Mh_teaUv0mneK6U5z1hveWQKWKSZadlR92PmO03oAo8Hn0pcc5zLiHxmUk_cz3m3kr3AlGaWUN7gYvLk2iOH3BCnLwaV5YMpDmJLsMWUMt5gV8u1_SdK2grYC09n09QP0MkzRl0FI0vWkF7hvaKFe3a39tuibXRYA7wAdQ0oRrNQuq3ldpRW3lQTL-VzkkOV8LlKQInn3QHLj-ijc7GAoG7pyEGXSDrwG42I5C2mCe0z2D3MP0zc |
CitedBy_id | crossref_primary_10_1016_j_omtm_2025_101441 crossref_primary_10_1002_jimd_12637 crossref_primary_10_1038_mt_2013_176 crossref_primary_10_1172_JCI66611 crossref_primary_10_1128_JVI_00209_12 crossref_primary_10_1016_j_ymthe_2020_01_004 crossref_primary_10_3390_jcm9020589 crossref_primary_10_1371_journal_pone_0067748 crossref_primary_10_1111_hae_14023 crossref_primary_10_1177_01926233231201408 crossref_primary_10_1016_j_ymthe_2017_04_003 crossref_primary_10_1089_hum_2016_172 crossref_primary_10_1016_j_pharmthera_2019_107453 crossref_primary_10_1002_rmv_1762 crossref_primary_10_1089_crispr_2020_0025 crossref_primary_10_1038_mtm_2014_33 crossref_primary_10_1016_j_preteyeres_2020_100915 crossref_primary_10_3389_fimmu_2020_00670 crossref_primary_10_4049_jimmunol_1200620 crossref_primary_10_1016_j_omtm_2022_01_005 crossref_primary_10_1182_blood_2012_10_460733 crossref_primary_10_1016_j_omtn_2024_102280 crossref_primary_10_1038_mt_2012_153 crossref_primary_10_1016_j_omtm_2022_07_018 crossref_primary_10_1089_hgtb_2018_038 crossref_primary_10_1016_j_coviro_2016_06_001 crossref_primary_10_1089_hum_2023_119 crossref_primary_10_1016_j_omtm_2021_03_016 crossref_primary_10_1089_hum_2012_246 crossref_primary_10_1007_s40259_017_0255_0 crossref_primary_10_1089_hum_2014_050 crossref_primary_10_1186_1744_8069_10_54 crossref_primary_10_3389_fimmu_2021_666666 crossref_primary_10_1038_gt_2012_98 crossref_primary_10_1172_JCI122372 crossref_primary_10_1007_s40259_023_00585_7 crossref_primary_10_1182_blood_2013_01_306647 crossref_primary_10_1186_s11689_018_9234_0 crossref_primary_10_1016_j_omtm_2019_05_014 crossref_primary_10_1016_j_ymthe_2019_11_014 crossref_primary_10_1089_hum_2021_258 crossref_primary_10_1089_hum_2017_150 crossref_primary_10_1016_j_omtm_2019_12_008 crossref_primary_10_1016_j_ymthe_2019_12_010 crossref_primary_10_1055_a_1757_9810 crossref_primary_10_1146_annurev_virology_101416_041936 crossref_primary_10_3389_fimmu_2022_975803 crossref_primary_10_1016_j_omtm_2017_04_004 crossref_primary_10_1038_s41575_022_00729_0 crossref_primary_10_1089_hum_2023_225 crossref_primary_10_1089_hum_2020_113 crossref_primary_10_4049_jimmunol_1202905 crossref_primary_10_3389_fimmu_2021_753467 crossref_primary_10_3389_fimmu_2019_03110 crossref_primary_10_1208_s12248_021_00678_7 crossref_primary_10_1517_21678707_2015_1088780 crossref_primary_10_1096_fj_201801391R crossref_primary_10_1016_j_cellimm_2017_11_006 crossref_primary_10_1007_s10238_024_01541_7 crossref_primary_10_1016_j_ymthe_2023_07_020 crossref_primary_10_3390_biomedicines9060613 crossref_primary_10_1038_mt_2011_218 crossref_primary_10_23736_S2724_6302_21_02381_1 |
Cites_doi | 10.1038/sj.mt.6300090 10.1038/nm1371 10.1182/blood.V116.21.248.248 10.1073/pnas.94.11.5804 10.1038/mt.2008.87 10.1016/j.ymthe.2004.12.022 10.1038/nm1549 10.1073/pnas.92.16.7257 10.1038/mt.2010.267 10.1128/JVI.78.12.6381-6388.2004 10.1093/oxfordjournals.aje.a120913 10.1038/nm1358 10.1038/sj.gt.3300548 10.1128/JVI.02021-06 10.1073/pnas.0904514106 10.1371/journal.ppat.1000503 10.1089/hum.2007.001 10.1128/JVI.02497-06 10.1182/blood-2003-05-1446 10.4049/jimmunol.0900317 10.1182/blood-2004-07-2908 10.1016/j.ymthe.2005.09.009 10.1016/0092-8674(83)90342-2 10.1038/nature05115 10.1038/ng0797-270 10.1128/JVI.77.8.4911-4927.2003 10.1182/blood-2008-07-167510 10.1093/oxfordjournals.aje.a112394 10.1182/blood-2006-03-010181 10.1007/978-1-59745-170-3_28 10.1073/pnas.0937739100 10.1086/587993 10.1128/JVI.78.14.7392-7399.2004 |
ContentType | Journal Article |
Copyright | 2011 The American Society of Gene & Cell Therapy Copyright Nature Publishing Group Nov 2011 Copyright © 2011 The American Society of Gene & Cell Therapy 2011 The American Society of Gene & Cell Therapy |
Copyright_xml | – notice: 2011 The American Society of Gene & Cell Therapy – notice: Copyright Nature Publishing Group Nov 2011 – notice: Copyright © 2011 The American Society of Gene & Cell Therapy 2011 The American Society of Gene & Cell Therapy |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7QO 7T5 7U9 8FD FR3 H94 P64 7X8 5PM |
DOI | 10.1038/mt.2011.81 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Local Electronic Collection Information Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Proquest Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Biotechnology Research Abstracts Immunology Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Virology and AIDS Abstracts Biotechnology Research Abstracts Technology Research Database AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE MEDLINE - Academic Virology and AIDS Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
DocumentTitleAlternate | T Cell Responses to AAV Capsid |
EISSN | 1525-0024 |
EndPage | 2030 |
ExternalDocumentID | PMC3222540 4069954371 21587208 10_1038_mt_2011_81 S152500161632799X |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States--US Texas Pennsylvania |
GeographicLocations_xml | – name: Texas – name: Pennsylvania – name: United States--US |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: P01HL078810 – fundername: NCI NIH HHS grantid: P30 CA010815 – fundername: NHLBI NIH HHS grantid: P01 HL078810 – fundername: Howard Hughes Medical Institute – fundername: NCI NIH HHS grantid: CA10815 |
GroupedDBID | --- --K 0R~ 123 1B1 29M 2WC 36B 39C 3V. 4.4 53G 6I. 7X7 88E 8FE 8FH 8FI 8FJ AACTN AAEDW AAFTH AAIAV AALRI AAVLU AAXUO ABAWZ ABJNI ABMAC ABUDA ABUWG ABVKL ACGFO ACGFS ACPRK ADBBV ADFRT ADJPV ADMUD ADQMX AEDAW AENEX AFKRA AFTJW AGAYW AHMBA AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS ASPBG AVWKF AZFZN BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 DIK DU5 E3Z EBS EJD EMB EMOBN F5P FDB FEDTE FRP FYUFA GX1 HCIFZ HMCUK HVGLF HYE HZ~ IHE JIG JSO KQ8 LG5 LK8 M1P M41 M7P NCXOZ NQ- O9- OK1 P2P PQQKQ PROAC PSQYO RCE RIG RNS RNTTT ROL RPM RPZ SEW SSZ SV3 TR2 UHS UKHRP W2D XPP ZA5 ZMT AAMRU AAYWO AAYXX ABDGV ABWVN ACRPL ACVFH ADCNI ADNMO ADVLN AEUPX AFPUW AGCQF AIGII AKAPO AKBMS AKRWK AKYEP ALIPV APXCP CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AZQEC DWQXO EFKBS GNUQQ K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7QO 7T5 7U9 8FD FR3 H94 P64 7X8 5PM |
ID | FETCH-LOGICAL-c483t-5d086b0b077120fd24aeaf34d3af564d7099acf1cb57a3c7c539d57f1ef3a3863 |
IEDL.DBID | 7X7 |
ISSN | 1525-0016 1525-0024 |
IngestDate | Thu Aug 21 14:08:32 EDT 2025 Fri Jul 11 06:37:17 EDT 2025 Mon Jul 21 09:42:18 EDT 2025 Fri Jul 25 11:08:23 EDT 2025 Thu Apr 03 07:04:01 EDT 2025 Thu Apr 24 23:03:10 EDT 2025 Tue Jul 01 01:46:39 EDT 2025 Fri Feb 23 02:27:14 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | http://creativecommons.org/licenses/by-nc-nd/4.0 https://www.elsevier.com/tdm/userlicense/1.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c483t-5d086b0b077120fd24aeaf34d3af564d7099acf1cb57a3c7c539d57f1ef3a3863 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://dx.doi.org/10.1038/mt.2011.81 |
PMID | 21587208 |
PQID | 1791980942 |
PQPubID | 2042164 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3222540 proquest_miscellaneous_902330603 proquest_miscellaneous_1668268020 proquest_journals_1791980942 pubmed_primary_21587208 crossref_citationtrail_10_1038_mt_2011_81 crossref_primary_10_1038_mt_2011_81 elsevier_sciencedirect_doi_10_1038_mt_2011_81 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-11-01 |
PublicationDateYYYYMMDD | 2011-11-01 |
PublicationDate_xml | – month: 11 year: 2011 text: 2011-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Milwaukee |
PublicationTitle | Molecular therapy |
PublicationTitleAlternate | Mol Ther |
PublicationYear | 2011 |
Publisher | Elsevier Inc Elsevier Limited Nature Publishing Group |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited – name: Nature Publishing Group |
References | Gao, Alvira, Somanathan, Lu, Vandenberghe, Rux (bib13) 2003; 100 Nathwani, Tuddenham, Rosales, McIntosh, Riddell, Rustagi (bib30) 2010; 116 Nathwani, Gray, McIntosh, Ng, Zhou, Spence (bib9) 2007; 109 Radziewicz, Ibegbu, Fernandez, Workowski, Obideen, Wehbi (bib27) 2007; 81 Arruda, Stedman, Nichols, Haskins, Nicholson, Herzog (bib6) 2005; 105 Fox, Hall, Cooney (bib24) 1977; 105 McCoy, Tatsis, Korioth-Schmitz, Lasaro, Hensley, Lin (bib32) 2007; 81 Arruda, Schuettrumpf, Herzog, Nichols, Robinson, Lotfi (bib3) 2004; 103 Amara (bib19) 2009; 485 Yang, Xiang, Ertl, Wilson (bib28) 1995; 92 Gao, Vandenberghe, Alvira, Lu, Calcedo, Zhou (bib14) 2004; 78 Roy, Vandenberghe, Kryazhimskiy, Grant, Calcedo, Yuan (bib22) 2009; 5 Li, Murphy, Giles-Davis, Edmonson, Xiang, Li (bib11) 2007; 15 Wang, Figueredo, Calcedo, Lin, Wilson (bib12) 2007; 18 Reyes-Sandoval, Fitzgerald, Grant, Roy, Xiang, Li (bib21) 2004; 78 Toromanoff, Chérel, Guilbaud, Penaud-Budloo, Snyder, Haskins (bib10) 2008; 16 Sabatino, Mingozzi, Hui, Chen, Colosi, Ertl (bib16) 2005; 12 Wherry, Blattman, Murali-Krishna, van der Most, Ahmed (bib25) 2003; 77 Monahan, Samulski, Tazelaar, Xiao, Nichols, Bellinger (bib7) 1998; 5 Fox, Brandt, Wassermann, Hall, Spigland, Kogon (bib23) 1969; 89 Tatsis, Lasaro, Lin, Haut, Xiang, Zhou (bib31) 2009; 182 Mingozzi, Meulenberg, Hui, Basner-Tschakarjan, Hasbrouck, Edmonson (bib18) 2009; 114 Priddy, Brown, Kublin, Monahan, Wright, Lalezari, Merck V520-016 Study Group (bib33) 2008; 46 Samulski, Srivastava, Berns, Muzyczka (bib15) 1983; 33 Li, Tuyishime, Wu, Giles-Davis, Zhou, Xiao (bib29) 2011; 19 Manno, Pierce, Arruda, Glader, Ragni, Rasko (bib1) 2006; 12 Snyder, Miao, Patijn, Spratt, Danos, Nagy (bib5) 1997; 16 Mingozzi, Maus, Hui, Sabatino, Murphy, Rasko (bib2) 2007; 13 Herzog, Hagstrom, Kung, Tai, Wilson, Fisher (bib4) 1997; 94 Chattopadhyay, Price, Harper, Betts, Yu, Gostick (bib20) 2006; 12 Day, Kaufmann, Kiepiela, Brown, Moodley, Reddy (bib26) 2006; 443 Davidoff, Gray, Ng, Zhang, Zhou, Spence (bib8) 2005; 11 Brantly, Chulay, Wang, Mueller, Humphries, Spencer (bib17) 2009; 106 Snyder (10.1038/mt.2011.81_bib5) 1997; 16 Mingozzi (10.1038/mt.2011.81_bib2) 2007; 13 Amara (10.1038/mt.2011.81_bib19) 2009; 485 Wang (10.1038/mt.2011.81_bib12) 2007; 18 Roy (10.1038/mt.2011.81_bib22) 2009; 5 Sabatino (10.1038/mt.2011.81_bib16) 2005; 12 Monahan (10.1038/mt.2011.81_bib7) 1998; 5 Chattopadhyay (10.1038/mt.2011.81_bib20) 2006; 12 Fox (10.1038/mt.2011.81_bib24) 1977; 105 Tatsis (10.1038/mt.2011.81_bib31) 2009; 182 Wherry (10.1038/mt.2011.81_bib25) 2003; 77 Mingozzi (10.1038/mt.2011.81_bib18) 2009; 114 Fox (10.1038/mt.2011.81_bib23) 1969; 89 Gao (10.1038/mt.2011.81_bib13) 2003; 100 Reyes-Sandoval (10.1038/mt.2011.81_bib21) 2004; 78 Nathwani (10.1038/mt.2011.81_bib9) 2007; 109 Priddy (10.1038/mt.2011.81_bib33) 2008; 46 Manno (10.1038/mt.2011.81_bib1) 2006; 12 Davidoff (10.1038/mt.2011.81_bib8) 2005; 11 Arruda (10.1038/mt.2011.81_bib3) 2004; 103 Li (10.1038/mt.2011.81_bib29) 2011; 19 Brantly (10.1038/mt.2011.81_bib17) 2009; 106 Day (10.1038/mt.2011.81_bib26) 2006; 443 Gao (10.1038/mt.2011.81_bib14) 2004; 78 Arruda (10.1038/mt.2011.81_bib6) 2005; 105 Yang (10.1038/mt.2011.81_bib28) 1995; 92 Herzog (10.1038/mt.2011.81_bib4) 1997; 94 Nathwani (10.1038/mt.2011.81_bib30) 2010; 116 Li (10.1038/mt.2011.81_bib11) 2007; 15 McCoy (10.1038/mt.2011.81_bib32) 2007; 81 Radziewicz (10.1038/mt.2011.81_bib27) 2007; 81 Samulski (10.1038/mt.2011.81_bib15) 1983; 33 Toromanoff (10.1038/mt.2011.81_bib10) 2008; 16 |
References_xml | – volume: 19 start-page: 536 year: 2011 end-page: 546 ident: bib29 article-title: Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice publication-title: Mol Ther – volume: 11 start-page: 875 year: 2005 end-page: 888 ident: bib8 article-title: Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models publication-title: Mol Ther – volume: 12 start-page: 972 year: 2006 end-page: 977 ident: bib20 article-title: Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry publication-title: Nat Med – volume: 105 start-page: 3458 year: 2005 end-page: 3464 ident: bib6 article-title: Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model publication-title: Blood – volume: 485 start-page: 417 year: 2009 end-page: 424 ident: bib19 article-title: Methods for quantitating antigen-specific T cell responses using functional assays in rhesus macaques publication-title: Methods Mol Biol – volume: 114 start-page: 2077 year: 2009 end-page: 2086 ident: bib18 article-title: AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells publication-title: Blood – volume: 92 start-page: 7257 year: 1995 end-page: 7261 ident: bib28 article-title: Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo publication-title: Proc Natl Acad Sci USA – volume: 116 start-page: 114 year: 2010 ident: bib30 article-title: Early clinical trial results following administration of a low dose of a novel self complementary adeno-associated viral vector encoding human factor ix in two subjects with severe haemophilia B publication-title: Blood – volume: 12 start-page: 1023 year: 2005 end-page: 1033 ident: bib16 article-title: Identification of mouse AAV capsid-specific CD8+ T cell epitopes publication-title: Mol Ther – volume: 81 start-page: 6594 year: 2007 end-page: 6604 ident: bib32 article-title: Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors publication-title: J Virol – volume: 109 start-page: 1414 year: 2007 end-page: 1421 ident: bib9 article-title: Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates publication-title: Blood – volume: 89 start-page: 25 year: 1969 end-page: 50 ident: bib23 article-title: The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness publication-title: Am J Epidemiol – volume: 33 start-page: 135 year: 1983 end-page: 143 ident: bib15 article-title: Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV publication-title: Cell – volume: 5 start-page: 40 year: 1998 end-page: 49 ident: bib7 article-title: Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia publication-title: Gene Ther – volume: 443 start-page: 350 year: 2006 end-page: 354 ident: bib26 article-title: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression publication-title: Nature – volume: 78 start-page: 6381 year: 2004 end-page: 6388 ident: bib14 article-title: Clades of adeno-associated viruses are widely disseminated in human tissues publication-title: J Virol – volume: 12 start-page: 342 year: 2006 end-page: 347 ident: bib1 article-title: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response publication-title: Nat Med – volume: 94 start-page: 5804 year: 1997 end-page: 5809 ident: bib4 article-title: Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus publication-title: Proc Natl Acad Sci USA – volume: 5 start-page: e1000503 year: 2009 ident: bib22 article-title: Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates publication-title: PLoS Pathog – volume: 182 start-page: 6587 year: 2009 end-page: 6599 ident: bib31 article-title: Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens publication-title: J Immunol – volume: 46 start-page: 1769 year: 2008 end-page: 1781 ident: bib33 article-title: Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults publication-title: Clin Infect Dis – volume: 16 start-page: 1291 year: 2008 end-page: 1299 ident: bib10 article-title: Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle publication-title: Mol Ther – volume: 100 start-page: 6081 year: 2003 end-page: 6086 ident: bib13 article-title: Adeno-associated viruses undergo substantial evolution in primates during natural infections publication-title: Proc Natl Acad Sci USA – volume: 18 start-page: 185 year: 2007 end-page: 194 ident: bib12 article-title: Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets publication-title: Hum Gene Ther – volume: 77 start-page: 4911 year: 2003 end-page: 4927 ident: bib25 article-title: Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment publication-title: J Virol – volume: 13 start-page: 419 year: 2007 end-page: 422 ident: bib2 article-title: CD8(+) T-cell responses to adeno-associated virus capsid in humans publication-title: Nat Med – volume: 78 start-page: 7392 year: 2004 end-page: 7399 ident: bib21 article-title: Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes publication-title: J Virol – volume: 16 start-page: 270 year: 1997 end-page: 276 ident: bib5 article-title: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors publication-title: Nat Genet – volume: 103 start-page: 85 year: 2004 end-page: 92 ident: bib3 article-title: Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1 publication-title: Blood – volume: 106 start-page: 16363 year: 2009 end-page: 16368 ident: bib17 article-title: Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy publication-title: Proc Natl Acad Sci USA – volume: 105 start-page: 362 year: 1977 end-page: 386 ident: bib24 article-title: The Seattle Virus Watch. VII. Observations of adenovirus infections publication-title: Am J Epidemiol – volume: 15 start-page: 792 year: 2007 end-page: 800 ident: bib11 article-title: Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes publication-title: Mol Ther – volume: 81 start-page: 2545 year: 2007 end-page: 2553 ident: bib27 article-title: Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression publication-title: J Virol – volume: 15 start-page: 792 year: 2007 ident: 10.1038/mt.2011.81_bib11 article-title: Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes publication-title: Mol Ther doi: 10.1038/sj.mt.6300090 – volume: 12 start-page: 972 year: 2006 ident: 10.1038/mt.2011.81_bib20 article-title: Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry publication-title: Nat Med doi: 10.1038/nm1371 – volume: 116 start-page: 114 year: 2010 ident: 10.1038/mt.2011.81_bib30 article-title: Early clinical trial results following administration of a low dose of a novel self complementary adeno-associated viral vector encoding human factor ix in two subjects with severe haemophilia B publication-title: Blood doi: 10.1182/blood.V116.21.248.248 – volume: 94 start-page: 5804 year: 1997 ident: 10.1038/mt.2011.81_bib4 article-title: Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.94.11.5804 – volume: 16 start-page: 1291 year: 2008 ident: 10.1038/mt.2011.81_bib10 article-title: Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle publication-title: Mol Ther doi: 10.1038/mt.2008.87 – volume: 11 start-page: 875 year: 2005 ident: 10.1038/mt.2011.81_bib8 article-title: Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models publication-title: Mol Ther doi: 10.1016/j.ymthe.2004.12.022 – volume: 13 start-page: 419 year: 2007 ident: 10.1038/mt.2011.81_bib2 article-title: CD8(+) T-cell responses to adeno-associated virus capsid in humans publication-title: Nat Med doi: 10.1038/nm1549 – volume: 92 start-page: 7257 year: 1995 ident: 10.1038/mt.2011.81_bib28 article-title: Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.92.16.7257 – volume: 19 start-page: 536 year: 2011 ident: 10.1038/mt.2011.81_bib29 article-title: Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice publication-title: Mol Ther doi: 10.1038/mt.2010.267 – volume: 78 start-page: 6381 year: 2004 ident: 10.1038/mt.2011.81_bib14 article-title: Clades of adeno-associated viruses are widely disseminated in human tissues publication-title: J Virol doi: 10.1128/JVI.78.12.6381-6388.2004 – volume: 89 start-page: 25 year: 1969 ident: 10.1038/mt.2011.81_bib23 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a120913 – volume: 12 start-page: 342 year: 2006 ident: 10.1038/mt.2011.81_bib1 article-title: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response publication-title: Nat Med doi: 10.1038/nm1358 – volume: 5 start-page: 40 year: 1998 ident: 10.1038/mt.2011.81_bib7 article-title: Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia publication-title: Gene Ther doi: 10.1038/sj.gt.3300548 – volume: 81 start-page: 2545 year: 2007 ident: 10.1038/mt.2011.81_bib27 article-title: Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression publication-title: J Virol doi: 10.1128/JVI.02021-06 – volume: 106 start-page: 16363 year: 2009 ident: 10.1038/mt.2011.81_bib17 article-title: Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0904514106 – volume: 5 start-page: e1000503 year: 2009 ident: 10.1038/mt.2011.81_bib22 article-title: Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1000503 – volume: 18 start-page: 185 year: 2007 ident: 10.1038/mt.2011.81_bib12 article-title: Cross-presentation of adeno-associated virus serotype 2 capsids activates cytotoxic T cells but does not render hepatocytes effective cytolytic targets publication-title: Hum Gene Ther doi: 10.1089/hum.2007.001 – volume: 81 start-page: 6594 year: 2007 ident: 10.1038/mt.2011.81_bib32 article-title: Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors publication-title: J Virol doi: 10.1128/JVI.02497-06 – volume: 103 start-page: 85 year: 2004 ident: 10.1038/mt.2011.81_bib3 article-title: Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1 publication-title: Blood doi: 10.1182/blood-2003-05-1446 – volume: 182 start-page: 6587 year: 2009 ident: 10.1038/mt.2011.81_bib31 article-title: Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimens publication-title: J Immunol doi: 10.4049/jimmunol.0900317 – volume: 105 start-page: 3458 year: 2005 ident: 10.1038/mt.2011.81_bib6 article-title: Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model publication-title: Blood doi: 10.1182/blood-2004-07-2908 – volume: 12 start-page: 1023 year: 2005 ident: 10.1038/mt.2011.81_bib16 article-title: Identification of mouse AAV capsid-specific CD8+ T cell epitopes publication-title: Mol Ther doi: 10.1016/j.ymthe.2005.09.009 – volume: 33 start-page: 135 year: 1983 ident: 10.1038/mt.2011.81_bib15 article-title: Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV publication-title: Cell doi: 10.1016/0092-8674(83)90342-2 – volume: 443 start-page: 350 year: 2006 ident: 10.1038/mt.2011.81_bib26 article-title: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression publication-title: Nature doi: 10.1038/nature05115 – volume: 16 start-page: 270 year: 1997 ident: 10.1038/mt.2011.81_bib5 article-title: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors publication-title: Nat Genet doi: 10.1038/ng0797-270 – volume: 77 start-page: 4911 year: 2003 ident: 10.1038/mt.2011.81_bib25 article-title: Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment publication-title: J Virol doi: 10.1128/JVI.77.8.4911-4927.2003 – volume: 114 start-page: 2077 year: 2009 ident: 10.1038/mt.2011.81_bib18 article-title: AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells publication-title: Blood doi: 10.1182/blood-2008-07-167510 – volume: 105 start-page: 362 year: 1977 ident: 10.1038/mt.2011.81_bib24 article-title: The Seattle Virus Watch. VII. Observations of adenovirus infections publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a112394 – volume: 109 start-page: 1414 year: 2007 ident: 10.1038/mt.2011.81_bib9 article-title: Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates publication-title: Blood doi: 10.1182/blood-2006-03-010181 – volume: 485 start-page: 417 year: 2009 ident: 10.1038/mt.2011.81_bib19 article-title: Methods for quantitating antigen-specific T cell responses using functional assays in rhesus macaques publication-title: Methods Mol Biol doi: 10.1007/978-1-59745-170-3_28 – volume: 100 start-page: 6081 year: 2003 ident: 10.1038/mt.2011.81_bib13 article-title: Adeno-associated viruses undergo substantial evolution in primates during natural infections publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0937739100 – volume: 46 start-page: 1769 year: 2008 ident: 10.1038/mt.2011.81_bib33 article-title: Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults publication-title: Clin Infect Dis doi: 10.1086/587993 – volume: 78 start-page: 7392 year: 2004 ident: 10.1038/mt.2011.81_bib21 article-title: Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes publication-title: J Virol doi: 10.1128/JVI.78.14.7392-7399.2004 |
SSID | ssj0011596 |
Score | 2.300293 |
Snippet | Hepatic adeno-associated virus serotype 2 (AAV2)-mediated gene transfer failed to achieve sustained transgene product expression in human subjects. We... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2021 |
SubjectTerms | Adeno-associated virus Adolescent Adult Animals Antigens Capsid - immunology Cytokines Dependovirus - immunology Hemophilia Human subjects Humans Hypotheses Immunology Immunophenotyping Infections Lymphocytes Macaca mulatta Middle Aged Original Parvoviridae Infections - immunology Primates T-Lymphocytes - immunology T-Lymphocytes - metabolism Tumor necrosis factor-TNF Viruses Young Adult |
Title | Capsid-specific T-cell Responses to Natural Infections With Adeno-associated Viruses in Humans Differ From Those of Nonhuman Primates |
URI | https://dx.doi.org/10.1038/mt.2011.81 https://www.ncbi.nlm.nih.gov/pubmed/21587208 https://www.proquest.com/docview/1791980942 https://www.proquest.com/docview/1668268020 https://www.proquest.com/docview/902330603 https://pubmed.ncbi.nlm.nih.gov/PMC3222540 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagFYgLgvJKKZURXDhYdeI8nBMqbVctqKuq2sLeIie2tSuxyXaTPfAD-N_MON5AoeUYeSxZGT--GY-_j5D3SWI04hDGUxtDgKIMy2OpmZKyMmWsrczxcfL5OD29ij9Pk6lPuLW-rHKzJ7qNWjcV5sgPkEYzlxCMRB-X1wxVo_B21Uto3CfbSF2GJV3ZdAi4AOw4fS6U-GGIbTb0pEIeLLqevlOGdx1I_wLOv-sm_ziIRk_IY48g6WHv8qfknql3yINeU_LHDnl47m_Ln5GfR2oJk43ha0qsCKIThnl6etnXxZqWdg0dK8e8Qc98VVbd0m_zbkYPYUNqmPLeM5p-na_W2GdeU5f5b-mxE1eho1WzoJNZ0xraWDpuaqf7Ry-QxwKA7HNyNTqZHJ0yL7vAqliKjiUawpySlzzLwohbHcXKKCtiLZRN0lhnACpVZcOqTDIlqqxKRK6TzIbGCiVkKl6QrbqpzStCAUzEpay0jCxAAQ7duOFaAQwRIjQhD8iHzb8vKs9JjtIY3wt3Ny5ksegK9FMhw4C8G2yXPRPHrVZs48LCY4geGxRwRNxqv7fxc-FXb1v8nmsBeTs0w7pDJ6naNGuwSVOIzCSg7YDQO2xyAEQQknERkJf9zBlGDkhLZhGXAcluzKnBAGm_b7bU85mj_8a7McDZu_8f-WvyyKW_3bPJPbLVrdbmDeCnrtx3i2SfbH86GV9cwtfx2ZdfNhYePQ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ1Lb9NAEIBHJRWPC4LyqKHAIuDAYVXb68fmgFBpGyW0saoqpb2ZtXetRGrsEDtC_QH8HX4js-sHFFpuPXtsWZ7Z3W88L4C3vq-k5hBqB5mHDopQtO9xSQXnqUo8mfG-Lk4eR8HwxPt85p-twc-2FkanVbZ7otmoZZHqf-Tbuo1mn6Mz4n5cfKN6apSOrrYjNGqzOFAX39FlKz-M9lC_71x3sD_ZHdJmqgBNPc4q6kuk-MRO7DB0XDuTrieUyJgnmcj8wJMhMpNIMydN_FCwNEx91pd-mDkqY4LxgOFzb8G6x9CV6cH6p_3o6LiLWyAcmHom3_Wppqm2ISrj2_OqbhjKneuOwH8R9-9MzT-OvsEDuN8wK9mpjewhrKl8A27XUywvNuDOuInPP4Ifu2KB5k11_abOQSITqiMD5LjOxFUlqQoSCdPrg4yaPLC8JKezakp2cAssqGjsRUnyZbZc6XtmOTGxhpLsmXEuZLAs5mQyLUpFioxERW4mDZIj3TkD0fkxnNyISp5ALy9ytQkE8cVLeCq5myF82HibrWwpEHwYc5RjW_C-_fZx2nRB18M4zmMTjWc8nlex1lPMHQvedLKLuvfHlVK0VWHcUEtNIzEeSlfKb7V6jpv9oox_W7cFr7vLuNK1kkSuihXKBAH6ghz53gJyjUwfEQydQJtZ8LS2nO7Nke146NrcgvCSTXUCutH45Sv5bGoajutoHJL9s_-_-Su4O5yMD-PDUXTwHO6Zn--maHMLetVypV4gvVXJy2bJEPh606v0F_ByWmk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Capsid-specific+T-cell+Responses+to+Natural+Infections+With+Adeno-associated+Viruses+in+Humans+Differ+From+Those+of+Nonhuman+Primates&rft.jtitle=Molecular+therapy&rft.au=Li%2C+Hua&rft.au=Lasaro%2C+Marcio+O&rft.au=Jia%2C+Bei&rft.au=Lin%2C+Shih+Wen&rft.date=2011-11-01&rft.pub=Elsevier+Limited&rft.issn=1525-0016&rft.eissn=1525-0024&rft.volume=19&rft.issue=11&rft.spage=2021&rft_id=info:doi/10.1038%2Fmt.2011.81&rft.externalDocID=4069954371 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-0016&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-0016&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-0016&client=summon |